Sanjay Nayak

CIK: 0002012715

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)9 (81.8%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (18.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OCUL

OCULAR THERAPEUTIX, INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (11 total)

OCUL
OCULAR THERAPEUTIX, INC
Aug 24, 2026
Sale(S)
Direct
1.9K shares at avg. $10.78$20K
OCUL
OCULAR THERAPEUTIX, INC
May 26, 2026
Sale(S)
Direct
1.9K shares at avg. $8.20$15K
OCUL
OCULAR THERAPEUTIX, INC
Feb 23, 2026
Sale(S)
Direct
1.8K shares at avg. $8.28$15K
OCUL
OCULAR THERAPEUTIX, INC
Feb 12, 2026
Sale(S)
Direct
10.3K shares at avg. $9.04$94K
OCUL
OCULAR THERAPEUTIX, INC
Jan 2, 2026
Award(A)
Direct
64.9K shares-
OCUL
OCULAR THERAPEUTIX, INC
Nov 24, 2025
Sale(S)
Direct
1.9K shares at avg. $12.04$23K
OCUL
OCULAR THERAPEUTIX, INC
Aug 25, 2025
Sale(S)
Direct
1.9K shares at avg. $12.04$23K
OCUL
OCULAR THERAPEUTIX, INC
May 23, 2025
Sale(S)
Direct
1.9K shares at avg. $7.17$13K
OCUL
OCULAR THERAPEUTIX, INC
Feb 24, 2025
Sale(S)
Direct
1.9K shares at avg. $6.84$13K
OCUL
OCULAR THERAPEUTIX, INC
Feb 11, 2025
Award(A)
Direct
111K shares-
OCUL
OCULAR THERAPEUTIX, INC
Nov 25, 2024
Sale(S)
Direct
1.8K shares at avg. $9.00$16K

		Type	Shares	Price		Ownership
Aug 24, 2026	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	1,897	$10.78	$20,450	Direct
May 26, 2026	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	1,858	$8.20	$15,236	Direct
Feb 23, 2026	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	1,759	$8.28	$14,565	Direct
Feb 12, 2026	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	10,348	$9.04	$93,546	Direct
Jan 2, 2026	OCUL OCULAR THERAPEUTIX, INC	Award(A)	64,900	-	$0	Direct
Nov 24, 2025	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	1,878	$12.04	$22,611	Direct
Aug 25, 2025	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	1,885	$12.04	$22,695	Direct
May 23, 2025	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	1,862	$7.17	$13,351	Direct
Feb 24, 2025	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	1,895	$6.84	$12,962	Direct
Feb 11, 2025	OCUL OCULAR THERAPEUTIX, INC	Award(A)	111,000	-	-	Direct
Nov 25, 2024	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	1,814	$9.00	$16,326	Direct

1-11 of 11 transactions

About Nayak Sanjay

Nayak Sanjay (SEC CIK 0002012715) files insider reports with the SEC as Chief Strategy Officer of OCULAR THERAPEUTIX, INC (OCUL).

Signal8 holds 11 ownership filings by Nayak Sanjay, all Form 4s, filed between Nov 27, 2024 and Aug 26, 2026. Those filings report 11 transactions, from Nov 25, 2024 to Aug 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Nayak Sanjay's filings is in BEDFORD, MA.

Recent filings by Nayak Sanjay

Aug 24, 2026: Open-market sale of OCUL shares (Form 4, code S).
May 26, 2026: Open-market sale of OCUL shares (Form 4, code S).
Feb 23, 2026: Open-market sale of OCUL shares (Form 4, code S).
Feb 12, 2026: Open-market sale of OCUL shares (Form 4, code S).
Jan 2, 2026: Grant or award of OCUL shares (Form 4, code A).

Other insiders filing for OCULAR THERAPEUTIX, INC (OCUL)

Anderman Todd, Chief Legal Officer
Kaiser Peter, Chief Development Officer
Heier Jeffrey S., Chief Scientific Officer
Notman Donald, Chief Operating Officer
Dugel Pravin
Warden Charles M, Director

How to read Form 4 transaction codes